US Edition
Weekly roundup: Sanofi seals a US$1.6bn deal with Vicebio and collaborates with Kling - Optimum Strategic Communications
Summary by Optimum Strategic Communications
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Weekly roundup: Sanofi seals a US$1.6bn deal with Vicebio and collaborates with Kling - Optimum Strategic Communications
Sanofi to acquire next-generation vaccine biotech Vicebio for US$1.6 billion Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to be acquired by Sanofi. Under the terms of the agreement, and subject to customary conditions, Vicebio shareholders will receive up to a total of US$1.6 billion, […] The post Weekly roundup: Sanofi seals a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
